Immunocore

Immunocore Entered Into an Oncology Collaboration and Licensing Agreement with MedImmune
Jan 9, 2014
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with ...

Tags: Immunocore, oncology research, collaboration and licensing agreement